“…For example, several studies demonstrated that IL-17A impairs the proliferation of progenitors ( Cui et al, 2019 ) and the production of newly generated neurons ( Liu et al, 2014 ), while other studies showed no difference in the proliferation ( Rueda et al, 2018 ; Tfilin and Turgeman, 2019 ; Willinger and Turgeman, 2022 ) and conflicting results on neurogenesis ( Tfilin and Turgeman, 2019 ; Willinger and Turgeman, 2022 ). These controversial findings are also reported in multiple brain diseases including stroke, Down syndrome, and post-traumatic stress disorder (PTSD), i.e., (1) anti-proliferative effects by IL-17A in Down syndrome and PTSD vs. inhibitory or no effects on cell proliferation in stroke, and (2) inhibition of neurogenesis in PTSD vs. inhibition or promotion of neurogenesis in stroke ( Lin et al, 2016 ; Rueda et al, 2018 ; Sun et al, 2020a , b ; Willinger and Turgeman, 2022 ). These results suggest that the neurobiological response to IL-17A may be differentially regulated depending on different microenvironmental stimuli.…”